MMP2 and ovarian carcinoma: The purpose of the present study was to determine the diagnostic utility of selected MMPs, MMP-2, MMP-3, MMP-11 and MMP-26, as new biomarkers in patients with ovarian cancer and to compare the results obtained with routinely determined markers CA125 and HE4 and the ROMA algorithm.